Results 171 to 180 of about 617,017 (357)
Adenosine; adenosine deaminase (ADA); adenosine A2B receptor (ADORA2B) [PDF]
openaire +1 more source
Cytoprotection Concepts for Ischemic Stroke in the Recanalization Era
This review provides detailed information on modern cytoprotective strategies for ischemic stroke in the context of recanalization therapies. It derives their rationale based on contemporary knowledge of stroke pathophysiology and discusses the role of advanced imaging approaches as well as concepts for novel clinical trial designs.
Johannes Boltze, Marc Fisher
wiley +1 more source
Estudo Abrangente do Resveratrol Associado à Sulfadiazina em Linfócitos Infectados com Toxoplasma gondii: Envolvimento da Sinalização Purinérgica na Resposta Imunológica. [PDF]
Bottari NB +11 more
europepmc +1 more source
Adenosine and the Cardiovascular System
A. Reiss +8 more
semanticscholar +1 more source
This study investigates the genetic and microbial factors influencing the susceptibility of Diaphorina citri to the citrus greening pathogen Candidatus Liberibacter asiaticus (CLas), employing a microbiome Genome Wide Association Study. The research identifies a key gene encoding an MFS‐type transporter contributing to CLas infectivity and abundance in
Kai Liu +12 more
wiley +1 more source
Autocrine Regulation of Volume-sensitive Anion Channels in Airway Epithelial Cells by Adenosine [PDF]
Luciana Musante +4 more
openalex +1 more source
The impact of and changes in the oxidative status in the post-injury period following nonpenetrating traumatic brain injuries. [PDF]
Lekomtseva Y, Belousov A, Vitaliy T.
europepmc +1 more source
GPCRs in CAR‐T Cell Immunotherapy: Expanding the Target Landscape and Enhancing Therapeutic Efficacy
Chimeric antigen receptor T cell therapy faces dual challenges of target scarcity and an immunosuppressive microenvironment in solid tumors. This review highlights how G protein‐coupled receptors can serve as both novel targets to expand the therapeutic scope and functional modules to enhance CAR‐T cell efficacy.
Zhuoqun Liu +11 more
wiley +1 more source

